DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Ophthalmology Drug Development Pipeline Review, 2016” report to their offering. The report provides comprehensive information on the pipeline development landscape for gla…
BromSite for the treatment of postoperative inflammation and prevention of ocular pain is now available in the United States, Sun Pharma announced in a press release.BromSite (bromfenac ophthalmic solution 0.075%) was approved by the FDA on April 8 and…
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Glaucoma Pipeline Highlights – 2016 Update” drug pipelines to their offering. Glaucoma Pipeline Highlights – 2016 Update, provides most up-to-date information on key pipel…
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Ophthalmology Pipeline Database – 2016 Update” report to their offering. Ophthalmology Pipeline Highlights Database 2016 Update covers emerging therapies for Ophthalmology…
At OSN New York, George O. Waring IV, MD, discusses the emerging subspecialty of surgical correction of presbyopia, with a focus on corneal based procedures for management of the stage 1 dysfunctional lens syndrome.
At OSN New York 2016, John W. Kitchens, MD, discusses ways the anterior segment specialist can partner with a retina specialist, sharing ideas from both a business standpoint and a surgical standpoint.